These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6084150)

  • 1. Advances in cardiovascular pharmacology.
    Goldberg LI
    J Cardiovasc Pharmacol; 1984; 6 Suppl 6():S922-7. PubMed ID: 6084150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New inotropic drugs].
    Presbitero P; Chiotti D
    Cardiologia; 1988 Aug; 33(8):747-53. PubMed ID: 2904301
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of amrinone and milrinone on calcium influx into the myocardium.
    Sutko JL; Kenyon JL; Reeves JP
    Circulation; 1986 Mar; 73(3 Pt 2):III52-8. PubMed ID: 3002664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Some advances in cardiovascular pharmacology (author's transl)].
    Ding GS
    Sheng Li Ke Xue Jin Zhan; 1981 Feb; 12(2):97-103. PubMed ID: 6118953
    [No Abstract]   [Full Text] [Related]  

  • 5. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.
    Travill CM; Pugh S; Noble MI
    Clin Ther; 1994; 16(5):783-92. PubMed ID: 7859237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autonomic nervous system dysfunction alters drug effects: implications for testing drugs for the treatment of heart failure.
    Hof RP; Novosel D; Evenou JP; Hof A
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):125-30. PubMed ID: 1383621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of the effect of cardiovascular drugs by impedance cardiography in healthy subjects.
    Lücker PW; Venitz J; Adolph S; Hey B
    Methods Find Exp Clin Pharmacol; 1986 Jul; 8(7):443-8. PubMed ID: 2876133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacology of cardiac and vascular tissues in heart failure.
    Godfraind T
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S1-20. PubMed ID: 2483434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New cardiotonic agents].
    Komajda M
    Ann Cardiol Angeiol (Paris); 1985 Dec; 34(10):681-8. PubMed ID: 2936298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interaction of amrinone and milrinone with endogenous adenosine in isolated atria of goats].
    Dorigo P; Gaion RM; Giacometti A; Marcomini A; Maragno I
    Cardiologia; 1987 Mar; 32(3):293-9. PubMed ID: 3607800
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current data regarding new positive inotropic drugs].
    Popescu P; Nanea T
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987; 39(3):211-26. PubMed ID: 2891169
    [No Abstract]   [Full Text] [Related]  

  • 12. Inotropic drugs for treatment of the failing heart.
    Maskin CS; Le Jemtel TH; Sonnenblick EH
    Cardiovasc Clin; 1984; 14(3):1-17. PubMed ID: 6327040
    [No Abstract]   [Full Text] [Related]  

  • 13. [Synthesis of 3-substituted 6-methyl-4-pyridyl-2 (1H) pyridones and testing of their cardiovascular action].
    Hanfeld V; Leistner S; Wagner G; Lohmann D; Poppe H; Heer S
    Pharmazie; 1988 Oct; 43(10):677-9. PubMed ID: 3212010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dopexamine hydrochloride on calcium channels in isolated guinea pig ventricular myocytes.
    Dun W; Zhao RR; Liang Y; Wu BW
    Methods Find Exp Clin Pharmacol; 1996; 18(6):353-7. PubMed ID: 8892264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pharmacological agents on exercise testing and exercise training of the coronary patient.
    Wenger NK
    Ann Acad Med Singap; 1983 Jul; 12(3):338-42. PubMed ID: 6146286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interaction between digoxin, beta-blockers, calcium antagonists, and other cardiac drugs].
    Hertzeanu H; Pines A
    Harefuah; 1986 Sep; 111(5-6):138-40. PubMed ID: 2879778
    [No Abstract]   [Full Text] [Related]  

  • 17. Description of time- and frequency- domain-based measures of heart rate variability in individuals taking antiarrhythmics, beta blockers, calcium channel blockers, and/or antihypertensive drugs after sudden cardiac arrest.
    Cowan MJ; Pike K; Burr RL; Cain KC; Narayanan SB
    J Electrocardiol; 1993; 26 Suppl():1-13. PubMed ID: 7910623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic response and effects on myocardial energetics of 3-cyano-2-morpholino-5-(pyrid-4-yl)pyridine (AWD 122-14) in anesthetized minipigs.
    Rohde E; Wiesner B; Muschick P
    Pharmazie; 1993 Sep; 48(9):690-4. PubMed ID: 8234405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis for the cardiovascular activities of amrinone and AR-L57.
    Hayes JS; Bowling N; Boder GB; Kauffman R
    J Pharmacol Exp Ther; 1984 Jul; 230(1):124-32. PubMed ID: 6086873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New cardiac drugs.
    Kikura M; Levy JH
    Int Anesthesiol Clin; 1995; 33(1):21-37. PubMed ID: 7635556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.